Meanwhile, Kaplan-Meier survival analysis in TCGA cohorts revealed that lower expression of HOXA7 and HOXD8, and higher expression of HOXA9, HOXA11, and HOXB9 were associated with worse overall survival in ccRCC patients (Figures 11A–H). Here, HOXB9 is linked to nonpapillary renal cell carcinoma.